icon-folder.gif   Conference Reports for NATAP  
 
  16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Safety, Efficacy, and Pharmacokinetics of the Integrase Inhibitor-Based E/C/F/TAF Single-Tablet Regimen in Treatment-Na´ve HIV-Infected Adolescents Through 24 Weeks of Treatment
 
 
  Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy, May 26-28, 2015, Washington, DC, USA
 
Hilda Kizito,1 Aditya Gaur,2 Wasana Prasitsuebsai,3 Natella Rakhmanina,4 Eileen Lawson,5 Yongwu Shao,5 Sean Bennett,5 Andrew Cheng,5 Erin Quirk5 1Joint Clinical Research Centre, Kampala, Uganda; 2St Jude Children's Research Hospital, Memphis, Tennessee, USA; 3The HIV Netherlands Australia Thailand Research Collaboration, Bangkok, Thailand; 4Children's National Health System, Washington, DC, USA; 5Gilead Sciences, Inc., Foster City, California, USA
 
CROI: Safety, Efficacy and Pharmacokinetics of the Integrase Inhibitor-Based E/C/F/TAF Single-Tablet Regimen in Treatment-Na´ve HIV-Infected Adolescents Through 24 Weeks of Treatment - (03/16/15)

pharm1.gif

pharm2.gif

pharm3.gif

pharm4.gif

pharm5.gif

pharm6.gif